Literature DB >> 28658915

Memory T Cells (CD45RO) Role and Evaluation in Pathogenesis of Lichen Planus and Lichenoid Mucositis.

Mani Devi1, Dhanaraj Vijayalakshmi2, Kumar Dhivya3, Murali Janane4.   

Abstract

INTRODUCTION: Memory T cells have the ability to survive in a quiescent state for longer periods and are responsible for the rapid responses on subsequent exposure to antigen. Analyzing memory T cells in Oral Lichen planus (OLP) and Lichenoid Mucositis (LM) suggest that these cells may play a role in the immunopathogenic mechanisms. AIM: To identify and evaluate Memory T cells in Lichen Planus (LP), Lichenoid Mucositis (LM) and Normal Mucosa (NM) using CD45RO monoclonal antibody immunohistochemically.
MATERIALS AND METHODS: A total of 30 cases (15 cases of OLP and 15 cases of LM) clinically and histopathologically diagnosed, and 10 cases of NM were stained for CD45RO monoclonal antibody, immunohistochemically using Biotin Streptavidin method. Staining intensity of CD45RO expression was statistically analysed using Chi-square Test.
RESULTS: The present study demonstrated a higher expression of CD45RO in connective tissue layer of OLP (53.3% intense staining) when compared to LM (20% intense staining) and no intense staining in NM. The difference in staining intensity pattern between the study groups was statistically significant (p=0.014).
CONCLUSION: This study demonstrates a statistically significant rise in memory T cells in LP than in LM, indicating the possible different immunopathogenic mechanisms.

Entities:  

Keywords:  Immune response; Immunohistochemistry; Naïve human T cells

Year:  2017        PMID: 28658915      PMCID: PMC5483817          DOI: 10.7860/JCDR/2017/26866.9930

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  14 in total

1.  Peripheral T-cell subsets in patients with reticular and atrophic-erosive oral lichen planus.

Authors:  I Rodríguez-Núñez; A Blanco-Carrión; A G García; J G Rey
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2001-02

Review 2.  Qualitative differences between naïve and memory T cells.

Authors:  Marion Berard; David F Tough
Journal:  Immunology       Date:  2002-06       Impact factor: 7.397

3.  Th1 cytokines in oral lichen planus.

Authors:  Ambereen Khan; Camile S Farah; Neil W Savage; Laurence J Walsh; Doug J Harbrow; Philip B Sugerman
Journal:  J Oral Pathol Med       Date:  2003-02       Impact factor: 4.253

Review 4.  Oral lichen planus. A review.

Authors:  P Jungell
Journal:  Int J Oral Maxillofac Surg       Date:  1991-06       Impact factor: 2.789

Review 5.  Oral manifestations of dermatologic disease: a focus on lichenoid lesions.

Authors:  Susan Müller
Journal:  Head Neck Pathol       Date:  2011-01-11

Review 6.  Update on the diagnosis of lichenoid dermatitis.

Authors:  A S Boyd
Journal:  Adv Dermatol       Date:  1996

Review 7.  Immunologic aspects of dermal and oral lichen planus: a review.

Authors:  S R Porter; A Kirby; I Olsen; W Barrett
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  1997-03

8.  Intra-epithelial subpopulations of T lymphocytes and Langerhans cells in oral lichen planus.

Authors:  L J Walton; M G Macey; M H Thornhill; P M Farthing
Journal:  J Oral Pathol Med       Date:  1998-03       Impact factor: 4.253

9.  Expression of CD1 and HLA-DR by Langerhans cells (LC) in oral lichenoid drug eruptions (LDE) and idiopathic oral lichen planus (LP).

Authors:  B E McCartan; P J Lamey
Journal:  J Oral Pathol Med       Date:  1997-04       Impact factor: 4.253

10.  Expression of lymphocyte function-associated antigen 3 in oral lichen planus.

Authors:  A C Kirby; I Olsen; P M Farthing; S R Porter
Journal:  Oral Dis       Date:  1995-12       Impact factor: 3.511

View more
  2 in total

1.  Analysis of Immunologic Function Changes in Lichen Planus After Clinical Treatment.

Authors:  Hua Qian; Liyan Jiao; Zhixia Fan; Litao Wang; Baoguo Liu; Guoying Miao
Journal:  Med Sci Monit       Date:  2018-12-02

2.  Oral lichen planus interactome reveals CXCR4 and CXCL12 as candidate therapeutic targets.

Authors:  César Rivera; Mariangela Fernanda Crisóstomo; Carolina Peña; Paulina González-Díaz; Wilfredo Alejandro González-Arriagada
Journal:  Sci Rep       Date:  2020-03-25       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.